• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年晚期高 BMI 预测未来严重肝脏疾病和肝细胞癌:一项针对 120 万男性的全国性、基于人群的队列研究。

High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.

机构信息

Centre for Digestive Diseases, Division of Hepatology, Karolinska University Hospital, Stockholm, Sweden.

Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.

出版信息

Gut. 2018 Aug;67(8):1536-1542. doi: 10.1136/gutjnl-2016-313622. Epub 2017 Mar 20.

DOI:10.1136/gutjnl-2016-313622
PMID:28320770
Abstract

OBJECTIVE

A high body mass index (BMI) is associated with an increased risk for severe liver disease. It is unclear if this risk differs across BMI categories, and if the association is partially attributed to development of type 2 diabetes mellitus (T2DM).

DESIGN

We used register data from more than 1.2 million Swedish men enlisted for conscription between 1969 and 1996. Data regarding new events of severe liver disease and T2DM during follow-up were obtained by record-linkage of population-based registers. We used Cox regression to estimate adjusted HRs for future inpatient care and mortality in severe liver disease and incidence of hepatocellular carcinoma (HCC) across BMI categories, using BMI of 18.5-22.5 kg/m as reference.

RESULTS

During a follow-up of more than 34 million person-years, 5281 cases of severe liver disease including 251 cases of HCC were identified. An association with severe liver disease was found for overweight (HR 1.49, 95% CI 1.35 to 1.64) and for obese men (HR 2.17, 95% CI 1.82 to 2.59). Development of T2DM further increased the risk for severe liver disease across all BMI categories, for instance, men with obesity and T2DM had a higher risk of severe liver disease (HR 3.28, 95% CI 2.27 to 4.74) than men with obesity free of T2DM (HR 1.72, 95% CI 1.72 to 2.54).

CONCLUSIONS

A high BMI in late adolescent men was associated with an increased risk of future severe liver disease, including HCC. Development of T2DM during follow-up was associated with a further increased risk of severe liver disease, independent of baseline BMI.

摘要

目的

高身体质量指数(BMI)与严重肝脏疾病的风险增加相关。目前尚不清楚这种风险是否因 BMI 类别而异,以及这种关联是否部分归因于 2 型糖尿病(T2DM)的发展。

设计

我们使用了来自 1969 年至 1996 年间应征入伍的超过 120 万瑞典男性的登记数据。通过基于人群的登记册的记录链接,获得了随访期间严重肝脏疾病和 T2DM 的新发病例数据。我们使用 Cox 回归估计了不同 BMI 类别下严重肝脏疾病的未来住院治疗和死亡率以及肝细胞癌(HCC)的发病率的校正 HR,以 BMI 为 18.5-22.5 kg/m2 作为参考。

结果

在超过 3400 万人年的随访期间,确定了 5281 例严重肝脏疾病病例,包括 251 例 HCC。超重(HR 1.49,95%CI 1.35-1.64)和肥胖男性(HR 2.17,95%CI 1.82-2.59)与严重肝脏疾病相关。在所有 BMI 类别中,T2DM 的发展进一步增加了严重肝脏疾病的风险,例如,患有肥胖症和 T2DM 的男性发生严重肝脏疾病的风险高于没有肥胖症且没有 T2DM 的男性(HR 3.28,95%CI 2.27-4.74)(HR 1.72,95%CI 1.72-2.54)。

结论

青少年晚期男性的高 BMI 与未来严重肝脏疾病(包括 HCC)的风险增加相关。在随访期间发生 T2DM 与严重肝脏疾病的风险进一步增加相关,与基线 BMI 无关。

相似文献

1
High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men.青少年晚期高 BMI 预测未来严重肝脏疾病和肝细胞癌:一项针对 120 万男性的全国性、基于人群的队列研究。
Gut. 2018 Aug;67(8):1536-1542. doi: 10.1136/gutjnl-2016-313622. Epub 2017 Mar 20.
2
Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.酒精性或病毒性丙型肝硬化患者肝细胞癌的危险因素。
Clin Gastroenterol Hepatol. 2006 Aug;4(8):1062-8. doi: 10.1016/j.cgh.2006.05.013. Epub 2006 Jul 14.
3
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes.2 型糖尿病患者发生严重肝脏疾病的危险因素。
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2769-2775.e4. doi: 10.1016/j.cgh.2019.04.038. Epub 2019 Apr 19.
4
Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study.青少年晚期超重预示着日后会发生严重的肝脏疾病:一项 39 年随访研究。
J Hepatol. 2016 Aug;65(2):363-8. doi: 10.1016/j.jhep.2016.03.019. Epub 2016 Jun 16.
5
Association of fasting serum glucose level and type 2 diabetes with hepatocellular carcinoma in men with chronic hepatitis B infection: A large cohort study.空腹血糖水平及 2 型糖尿病与慢性乙型肝炎感染男性肝细胞癌的相关性:一项大型队列研究。
Eur J Cancer. 2018 Oct;102:103-113. doi: 10.1016/j.ejca.2018.07.008. Epub 2018 Sep 4.
6
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
7
[Body mass index and cancer incidence:a prospective cohort study in northern China].[体重指数与癌症发病率:中国北方的一项前瞻性队列研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6.
8
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.他汀类药物对2型糖尿病患者肝细胞癌的影响:一项全国性巢式病例对照研究。
Int J Cancer. 2017 Feb 15;140(4):798-806. doi: 10.1002/ijc.30506. Epub 2016 Nov 16.
9
Body mass index in childhood and adult risk of primary liver cancer.儿童时期的体重指数与原发性肝癌的成人发病风险。
J Hepatol. 2014 Feb;60(2):325-30. doi: 10.1016/j.jhep.2013.09.015. Epub 2013 Sep 26.
10
Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men.肥胖和酒精协同作用会增加男性发生肝细胞癌的风险。
Clin Gastroenterol Hepatol. 2010 Oct;8(10):891-8, 898.e1-2. doi: 10.1016/j.cgh.2010.06.027. Epub 2010 Aug 17.

引用本文的文献

1
The association between childhood obesity and major adverse liver outcomes in adolescence and young adulthood.儿童肥胖与青少年及青年期严重肝脏不良结局之间的关联。
JHEP Rep. 2025 Apr 11;7(7):101425. doi: 10.1016/j.jhepr.2025.101425. eCollection 2025 Jul.
2
Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD.线粒体功能障碍是母体肥胖对代谢相关脂肪性肝病多代影响的特征。
JHEP Rep. 2025 Mar 29;7(6):101404. doi: 10.1016/j.jhepr.2025.101404. eCollection 2025 Jun.
3
Association of overweight/obesity and digestive system cancers: A meta-analysis and trial sequential analysis of prospective cohort studies.
超重/肥胖与消化系统癌症的关联:一项前瞻性队列研究的荟萃分析和试验序贯分析
PLoS One. 2025 Apr 1;20(4):e0318256. doi: 10.1371/journal.pone.0318256. eCollection 2025.
4
Assessing the effect of modifiable risk factors on hepatocellular carcinoma: evidence from a bidirectional Mendelian randomization analysis.评估可改变的风险因素对肝细胞癌的影响:来自双向孟德尔随机化分析的证据。
Discov Oncol. 2025 Mar 31;16(1):437. doi: 10.1007/s12672-025-02177-z.
5
Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study.糖尿病和肥胖合并症对肝细胞癌切除术后生存结局的影响:一项多中心回顾性研究
Liver Cancer. 2024 Aug 20;14(1):80-91. doi: 10.1159/000540858. eCollection 2025 Mar.
6
Methyl -Butyl Ether May Be a Potential Environmental Pathogenic Factor for Nonalcoholic Fatty Liver Disease: Results from NHANES 2017-2020.甲基叔丁基醚可能是非酒精性脂肪性肝病的潜在环境致病因素:2017 - 2020年美国国家健康与营养检查调查结果
Environ Health (Wash). 2024 Nov 7;3(2):190-198. doi: 10.1021/envhealth.4c00140. eCollection 2025 Feb 21.
7
Novel translational mouse models of metabolic dysfunction-associated steatotic liver disease comparable to human MASLD with severe obesity.与伴有严重肥胖的人类代谢功能障碍相关脂肪性肝病(MASLD)可比的新型代谢功能障碍相关脂肪性肝病的转化小鼠模型。
Mol Metab. 2025 Mar;93:102104. doi: 10.1016/j.molmet.2025.102104. Epub 2025 Jan 22.
8
Investigation of Active Components of (Maxim.) Franch in Mitigating Non-Alcoholic Fatty Liver Disease.( Maxim.) Franch减轻非酒精性脂肪性肝病活性成分的研究
Int J Mol Sci. 2024 Dec 24;26(1):50. doi: 10.3390/ijms26010050.
9
Risk-stratified hepatocellular carcinoma screening according to the degree of obesity and progression to cirrhosis for diabetic patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Japan: a cost-effectiveness study.日本代谢相关脂肪性肝病(MASLD)伴糖尿病患者,根据肥胖程度和向肝硬化进展进行风险分层的肝细胞癌筛查:成本效益研究。
BMJ Open. 2024 Nov 5;14(11):e080549. doi: 10.1136/bmjopen-2023-080549.
10
Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease.代谢综合征与饮酒之间的相互作用会增加患肝病的风险。
United European Gastroenterol J. 2024 Mar;12(2):168-176. doi: 10.1002/ueg2.12524. Epub 2024 Feb 21.